Federated Hermes’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.69K	Buy	+531	New	+$2.69K	﹤0.01%	1943
2023 Q4	–	Sell	-20,000	Closed	-$153K	–	2185
2023 Q3	$153K	Buy	+20,000	New	+$153K	﹤0.01%	1560